| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President | Chief Development Officer
2 companies
Turkel Catherine C. is a President at ELDN, with reported holdings spanning 2 companies. Recent filings cover 6 purchases and 2 sales. Those positions are worth an estimated $179K at current prices.
Turkel Catherine C.'s largest disclosed position is in ELDN as President, worth about $169K. Net of sales, the recent Form 4 record there shows accumulation of 36,059 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | LEXX Lexaria Bioscience Corp. | Director | Buy | 1,600 | $3.13 | $5,008.00 | +106.7% | -29.4% | -74.5% | |
| Feb 9, 2023 | LEXX Lexaria Bioscience Corp. | Director | Buy | 1,500 | $2.84 | $4,266.90 | New | -72.7% | -18.9% | |
| May 21, 2019 | ELDN Eledon Pharmaceuticals, Inc. | President | Sell | 9,537 | $1.95 | $18,611.70 | -9.7% | - | - | |
| Sep 12, 2018 | ELDN Eledon Pharmaceuticals, Inc. | President | Buy | 33,680 | $4.78 | $161,146.70 | +75.7% | - | - | |
| Sep 5, 2018 | ELDN Eledon Pharmaceuticals, Inc. | President | Buy | 805 | $3.97 | $3,192.63 | New | - | - | |
| May 10, 2017 | ELDN Eledon Pharmaceuticals, Inc. | Chief Development Officer | Buy | 11,111 | $9.99 | $110,998.89 | +82.9% | - | - |